Some internet users claim that Bharat Biotech’s Covid-19 vaccine Covaxin has received approval for use in children over the age of 12. India Today’s Anti-Fake News War Room (AFWA) has determined that at the time of submission of this article, only people over the age of 18 in India are eligible for Covid-19 vaccination.
India Today’s Anti-Fake News War Room (AFWA) has determined that at the time of submission of this article, only people over the age of 18 in India are eligible for Covid-19 vaccination.
Health experts have warned that children under 18 are at risk in the EU third wave of Covid-19 that may hit India in 3-4 months. The main reason for this is that they have not yet been vaccinated against the infection.
Meanwhile, some internet users claim that Bharat Biotech’s Covid-19 vaccine Covaxin has received approval for use in children over the age of 12. A Facebook users wrote: “Great News: Bharat Biotech (Made in India) Covaxin Approved for Children Over 12 Years”.
India Today’s Anti-Fake News War Room (AFWA) has determined that at the time of submission of this article, only people over the age of 18 in India are eligible for Covid-19 vaccination. However, Bharat Biotech received permission to conduct studies on children over the age of 12 for the Covid-19 vaccination.
Multiple users are share the post believe the information is true. The archived version is visible Here.
AFWA probe
The Press Information Bureau has refuted the viral claim, saying, “This claim is false. Such approval has not been given by the Government of India. Currently, citizens over the age of 18 can get the Covid-19 vaccination. “
After this Ministry of Health“The general practice is to first evaluate any new vaccine in the elderly population and then do an age reduction to evaluate safety and effectiveness in the pediatric population. The vaccines currently available have not yet been evaluated in children. A number of clinical studies are currently ongoing to test the effectiveness and safety of the Covid-19 vaccines in children. “
In January of this year, the Drugs Controller General of India (DCGI) approved Covaxin for testing in children over 12 years of age.
In the following month, however, a Expert committee the Central Drugs Standard Control Organization denied Bharat Biotech’s request to conduct clinical trials with Covaxin in children ages 5 to 18 and asked them to produce efficacy data for adults first.
However, it is clear that Covaxin is not currently approved for use in children over 12 years of age. It’s only in the testing phase.
READ: Fact Check: Edited clip shared as Foreign Minister Jaishankar violating Covid norms during the G7
ALSO READ: Fact Check: Is It Safe To Use An Oxygen Concentrator In An Enclosed Space?
claimBharat Biotech’s India-made Covid-19 vaccine, Covaxin, has been approved for use in children over the age of 12. ConclusionCovaxin has been approved for use in studies in children over the age of 12.
JHOOTH BOLE KAUVA KAATE
The number of crows determines the intensity of the lie.
- 1 crow: half true
- 2 crows: mostly lies
- 3 crows: absolutely wrong
Click here for IndiaToday.in full coverage of the coronavirus pandemic.
एक टिप्पणी भेजें